Metabical

SWOT Analysis is a Strategic Planning method that is used to evaluate the strengths, weaknesses, opportunities and threats of a business. It involves monitoring the internal and external marketing environment. Table 1 : SWOT Analysis i. FDA approval i.

SWOT ANALYSIS

STRENGTHS

i. Safe and effective in achieving discomfort.

ii. Significant weight loss

iii. Less harmful compared to other BMI>30 products.

iv. One pill per day

v. Average course treatment lasting12 weeks

vi. Combination of Calosera and meditanan created dramatic effect for weight loss

vii. Strong and Comprehensive marketing strategy

viii. Experience marketing and R&D team

ix. Allocate substantial amount of money in marketing budget WEAKNESSES

i. Negative side effect-gastrointestinal

ii. Not effective for individual with

OPPORTUNITIES

i. Comprehensive support program Health care plans to include Metabical

ii. No prescription ± drug options for overweight segment (BMI 25-30) available in 2008 except drug Alli approved by FDA

iii. Market research indicated of high indication of people wanting to loss weight.

THREATS

i. FDA imposed stringent regulation due to negative side-effect cases. in their prescription drug program

ii. Increasing herbal / dietary iii. Deceptive marketing claims

Target Market

Metabical will be marketed to overweight women of the age from 25-65. According to a 2007 marketing survey it was determined that women 10% more women then men are dissatisfied with their current weight, 20% more women then men visited a healthcare provider for a yearly physical, 15% more women then men want to change their behavior to live a healthy lifestyle, 30% more women then men failed to lose weight in the past 5 years, 30% more women then men were dissatisfied with current weight loss options on the market. These results make it clear that women are the most likely gender to purchase Metabical. The age group of 25-65 is justified because these women have expendable income...